“The aim of this cross-sectional questionnaire-based study was to identify associations between the doses of cannabinoids and terpenes administered, and symptoms of attention deficit hyperactivity disorder (ADHD).
CONCLUSION:
These findings reveal that the higher-dose consumption of medical cannabis (MC) components (phyto-cannabinoids and terpenes) is associated with ADHD medication reduction.
In addition, high dosage of CBN was associated with a lower ASRS score.
However, more studies are needed in order to fully understand if cannabis and its constituents can be used for management of ADHD.”